Citadel Advisors’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Buy
38,800
+17,500
+82% +$169K ﹤0.01% 10054
2025
Q4
$215K Sell
21,300
-38,600
-64% -$384K ﹤0.01% 10892
2025
Q3
$644K Buy
59,900
+21,300
+55% +$238K ﹤0.01% 8525
2025
Q2
$525K Buy
38,600
+8,500
+28% +$119K ﹤0.01% 8517
2025
Q1
$383K Buy
30,100
+17,400
+137% +$247K ﹤0.01% 9053
2024
Q4
$153K Sell
12,700
-44,000
-78% -$464K ﹤0.01% 10849
2024
Q3
$512K Buy
56,700
+45,000
+385% +$391K ﹤0.01% 8211
2024
Q2
$97.9K Buy
11,700
+2,200
+23% +$13.9K ﹤0.01% 10943
2024
Q1
$45.3K Sell
9,500
-3,500
-27% -$15.1K ﹤0.01% 12254
2023
Q4
$54.1K Buy
13,000
+1,900
+17% +$6.22K ﹤0.01% 11705
2023
Q3
$45K Buy
+11,100
New +$52.1K ﹤0.01% 11870

Other funds holding DCTH

Citadel Advisors's DCTH Position: Q1 2026 in Review

Citadel Advisors reduced its Delcath Systems (DCTH) stake by 79% in Q1 2026, selling an estimated $2.82M and leaving 77,264 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #8449.

Citadel Advisors first reported a position in DCTH in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.9M in Q2 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Citadel Advisors held 77,264 shares of Delcath Systems worth $717K as of Q1 2026.
  • Citadel Advisors sold 291,601 Delcath Systems shares in Q1 2026, an estimated $2.82M.
  • Delcath Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8449 holding.
  • Citadel Advisors first reported a position in Delcath Systems in Q4 2022 and has held it in 13 quarters since.
  • Citadel Advisors's Delcath Systems position peaked at $10.9M in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.